Novo Nordisk A/S - Scientific publications Showing results 21-40 Search Journal Author Year Physiologia Plantarum Modelling NADH turnover in plant mitochondria Hagedorn PH ; Flyvbjerg H ; Moller IM 2004 Journal of Pharmaceutical and Biomedical Analysis Development and validation of a high-resolution capillary electrophoresis method for multi-analysis of ragaglitazar and arginine in Active Pharmaceutical Ingredients and low...
Novo Nordisk A/S - Scientific publications Showing results 21-40 Search Journal Author Year Physiologia Plantarum Modelling NADH turnover in plant mitochondria Hagedorn PH ; Flyvbjerg H ; Moller IM 2004 Journal of Pharmaceutical and Biomedical Analysis Development and validation of a high-resolution capillary electrophoresis method for multi-analysis of ragaglitazar and arginine in Active Pharmaceutical Ingredients and low...
Novo Nordisk A/S - Novo Nordisk HRT Milestones HTML VERSION CONTACT US SITEMAP SEARCH Diabetes-care Biopharmaceuticals About-us R&D; Media Investors Sustainability Jobs Our history in HRT in HRT &sUrl;=/therapy_areas/hrt/our_hrt_products/hrt_milestones.asp','tellafriend','335','500')"> - 28 million women years of experience Milestones 1978 A- First with 28-day unopposed estradiol: Estrofem A® 1978 A- First with 28-day...
Novo Nordisk A/S - VagifemA® HTML VERSION CONTACT US SITEMAP SEARCH Diabetes-care Biopharmaceuticals About-us R&D; Media Investors Sustainability Jobs Vagifem A® A® &sUrl;=/therapy_areas/hrt/our_hrt_products/vagifem.asp','tellafriend','335','500')"> Vagifem A® is a local oestrogen therapy for effective relief of symptoms associated with vaginal dryness.
Novo Nordisk A/S - Our HRT products HTML VERSION CONTACT US SITEMAP SEARCH Diabetes-care Biopharmaceuticals About-us R&D; Media Investors Sustainability Jobs Introduction Novo Nordisk is one of the world’s largest manufactures of hormone replacement therapy (HRT) products.
Low-dose vaginal estrogen for dryness and atrophy - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Low-dose vaginal estrogen for dryness and atrophy - [Medication] - Quest Diagnostics Patient Health Library Low-dose vaginal estrogen for dryness and atrophy - [Medication] - Quest Diagnostics Patient Health Library Hormones, Sexual and reproductive organs,...
Novo Nordisk A/S - Scientific publications Showing results 881-900 Search Journal Author Year Expert Review of Molecular Diagnostics Application of genomics and proteomics in Type 1 diabetes pathogenesis research Sparre T ; Bergholdt R ; Nerup J ; Pociot F 2003 Journal of Clinical Pharmacology Pharmacokinetics of repaglinide in healthy Caucasian and Japanese subjects Thomsen MS ; Chassard D ; Evene E ; Nielsen KK ; Jorgensen...
Novo Nordisk A/S - Scientific publications Showing results 881-900 Search Journal Author Year Expert Review of Molecular Diagnostics Application of genomics and proteomics in Type 1 diabetes pathogenesis research Sparre T ; Bergholdt R ; Nerup J ; Pociot F 2003 Journal of Clinical Pharmacology Pharmacokinetics of repaglinide in healthy Caucasian and Japanese subjects Thomsen MS ; Chassard D ; Evene E ; Nielsen KK ; Jorgensen...
Novo Nordisk A/S - Scientific publications Showing results 741-760 Search Journal Author Year JOURNAL OF PEPTIDE SCIENCE Primary structure of fox (Vulpes vulpes) proinsulin based on sequence studies of pancreatic peptides and cDNA Fiertek, D ; Gromowska, M ; Andersen, AS ; Hansen, PH ; Majewski, T ; Izdebski, J 2000 Journal of Pharmaceutical and Biomedical Analysis Development and validation of a high-resolution capillary...
Novo Nordisk A/S - Scientific publications Showing results 741-760 Search Journal Author Year JOURNAL OF PEPTIDE SCIENCE Primary structure of fox (Vulpes vulpes) proinsulin based on sequence studies of pancreatic peptides and cDNA Fiertek, D ; Gromowska, M ; Andersen, AS ; Hansen, PH ; Majewski, T ; Izdebski, J 2000 Journal of Pharmaceutical and Biomedical Analysis Development and validation of a high-resolution capillary...
Novo Nordisk A/S - Scientific publications Showing results 741-760 Search Journal Author Year JOURNAL OF PEPTIDE SCIENCE Primary structure of fox (Vulpes vulpes) proinsulin based on sequence studies of pancreatic peptides and cDNA Fiertek, D ; Gromowska, M ; Andersen, AS ; Hansen, PH ; Majewski, T ; Izdebski, J 2000 Journal of Pharmaceutical and Biomedical Analysis Development and validation of a high-resolution capillary...
Novo Nordisk A/S - Scientific publications Showing results 641-660 Search Journal Author Year JOURNAL OF PHARMACEUTICAL SCIENCES Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy Nielsen, L ; Frokjaer, S ; Carpenter, JF ; Brange, J 2001 BIOCHEMISTRY Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular...
Novo Nordisk A/S - Scientific publications Showing results 641-660 Search Journal Author Year JOURNAL OF PHARMACEUTICAL SCIENCES Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy Nielsen, L ; Frokjaer, S ; Carpenter, JF ; Brange, J 2001 BIOCHEMISTRY Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular...
Novo Nordisk A/S - Scientific publications A new class of selective GSK-3 inhibitors Olesen PH ; Sorensen AR ; Urso B ; Kurtzhals P ; Bowler AN ; Ehrbar U ; Hansen BF 2003 Journal of Virological Methods Phage display of the Equine arteritis virus nsp1 ZF domain and examination of its metal interactions Oleksiewicz MB ; Snijder EJ ; Normann P 2004 Scandinavian Journal of Gastroenterology Stool protein analysis by two...
Novo Nordisk A/S - Scientific publications A new class of selective GSK-3 inhibitors Olesen PH ; Sorensen AR ; Urso B ; Kurtzhals P ; Bowler AN ; Ehrbar U ; Hansen BF 2003 Journal of Virological Methods Phage display of the Equine arteritis virus nsp1 ZF domain and examination of its metal interactions Oleksiewicz MB ; Snijder EJ ; Normann P 2004 Scandinavian Journal of Gastroenterology Stool protein analysis by two...
Novo Nordisk A/S - Scientific publications Showing results 221-240 Search Journal Author Year Journal of Thrombosis and Haemostasis The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX He S ; Blomback M ; Ekman GJ ; Hedner U 2003 JOURNAL OF THEORETICAL BIOLOGY Modeling the insulin-glucose feedback system: The significance of pulsatile insulin secretion Tolic, IM ; Mosekilde, E ; Sturis, J...
Novo Nordisk A/S - Scientific publications Showing results 221-240 Search Journal Author Year Journal of Thrombosis and Haemostasis The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX He S ; Blomback M ; Ekman GJ ; Hedner U 2003 JOURNAL OF THEORETICAL BIOLOGY Modeling the insulin-glucose feedback system: The significance of pulsatile insulin secretion Tolic, IM ; Mosekilde, E ; Sturis, J...
http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
Cancer.gov - Sexuality and Reproductive Issues(PDQ®) The approval of the estradiol -releasing vaginal ring (Estring), containing a slow-release preparation, 2 mg micronized 17beta-estradiol, may also provide a less risky alternative to systemic estrogen replacement for women with postmenopausal vaginal atrophy.[ 27 , 28 ] Estring has demonstrated a decreased recurrence of urinary tract infections in postmenopausal women and...
Annual Review 2002 page 27
author: Novo Nordisk
duplicates:http://www.novonordisk.com/images/about_us/corporate_governance/AR2002UK.pdf
Prescription and OTC Drug Product List 3/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 3: March 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CAPSULE; ORAL CHLORIDE; SODIUM PHOSPHATE...
FDA Drug Approvals List- March 1999 Drug Approvals for March 1999 Definitions and Notes March 1999 Original New Drug Applications Original Application #: 020966 Approval Date: 30-MAR-99 Trade Name: SPORANOX Chemical Type: 3 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: JANSSEN RESEARCH FDN DIV JOHNSON AND JOHNSON Active Ingredient(s): ITRACONAZOLE OTC/RX Status: RX Indication(s): For the treatment of...
20908LBL.PDF NDA 20- 908 VAGIFEM ™ 25 mg Physician Package Insert Novo Nordisk Page 2 of 23 Edition 3/ 26/ 99 DESCRIPTION VAGIFEM ™ (estradiol vaginal tablet) is a small, white, film- coated tablet containing 25.8 µg of estradiol hemihydrate equivalent to 25 µg of estradiol VAGIFEM, 17 ss- estradiol is...
author: Unknown
20908LBL.PDF page 22
author: Unknown
20908LBL.PDF page 6
author: Unknown
